Wealth Alliance’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Buy |
3,705
+258
| +7% | +$21.4K | 0.03% | 401 |
|
|
2025
Q1 | $280K | Sell |
3,447
-636
| -16% | -$51.6K | 0.03% | 408 |
|
|
2024
Q4 | $368K | Buy |
4,083
+173
| +4% | +$15.6K | 0.04% | 320 |
|
|
2024
Q3 | $386K | Buy |
3,910
+50
| +1% | +$4.94K | 0.05% | 337 |
|
|
2024
Q2 | $358K | Sell |
3,860
-181
| -4% | -$16.8K | 0.05% | 331 |
|
|
2024
Q1 | $383K | Buy |
4,041
+1,793
| +80% | +$170K | 0.05% | 331 |
|
|
2023
Q4 | $201K | Sell |
2,248
-2,578
| -53% | -$230K | 0.03% | 489 |
|
|
2023
Q3 | $352K | Sell |
4,826
-326
| -6% | -$23.8K | 0.06% | 307 |
|
|
2023
Q2 | $429K | Sell |
5,152
-241
| -4% | -$20.1K | 0.06% | 279 |
|
|
2023
Q1 | $411K | Sell |
5,393
-56
| -1% | -$4.27K | 0.07% | 279 |
|
|
2022
Q4 | $452K | Buy |
5,449
+225
| +4% | +$18.7K | 0.08% | 250 |
|
|
2022
Q3 | $414K | Buy |
5,224
+75
| +1% | +$5.94K | 0.08% | 248 |
|
|
2022
Q2 | $382K | Buy |
+5,149
| New | +$382K | 0.07% | 265 |
|
|
2021
Q3 | – | Sell |
-1,568
| Closed | -$212K | – | 453 |
|
|
2021
Q2 | $212K | Sell |
1,568
-25
| -2% | -$3.38K | 0.05% | 399 |
|
|
2021
Q1 | $216K | Sell |
1,593
-50
| -3% | -$6.78K | 0.06% | 365 |
|
|
2020
Q4 | $231K | Buy |
+1,643
| New | +$231K | 0.07% | 337 |
|